AlphaQuest’s Editas Medicine EDIT Stock Holding History

AlphaQuest’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,458	Closed	-$130K	–	1663
2024 Q1	$130K	Sell	17,458 -30,223	-63%	-$251K	0.02%	765
2023 Q4	$483K	Buy	+47,681	New	+$419K	0.1%	357

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

AlphaQuest's EDIT Position: Q2 2024 in Review

AlphaQuest sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 17,458 shares — an estimated $130K sold.

AlphaQuest first reported a position in EDIT in Q4 2023 and held it in 2 quarters. The position peaked at $483K in Q4 2023. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

AlphaQuest reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
AlphaQuest sold 17,458 Editas Medicine shares in Q2 2024, an estimated $130K.
AlphaQuest first reported a position in Editas Medicine in Q4 2023 and held it in 2 quarters.
AlphaQuest's Editas Medicine position peaked at $483K in Q4 2023.
235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on AlphaQuest's 13F filing for Q2 2024, filed 6 Aug 2024.